{"id":4695,"date":"2017-01-03T10:19:54","date_gmt":"2017-01-03T10:19:54","guid":{"rendered":"https:\/\/aspree.org\/aus\/?p=4695"},"modified":"2021-08-02T08:42:26","modified_gmt":"2021-08-02T08:42:26","slug":"aspree-aus-and-us-team-meet-up","status":"publish","type":"post","link":"https:\/\/aspree.org\/aus\/aspree-aus-and-us-team-meet-up\/","title":{"rendered":"ASPREE international researcher meet-up"},"content":{"rendered":"\r\n

Earlier this month we welcomed our\u00a0U.S. research collaborators from the Berman Center for Outcomes and Clinical Research,\u00a0along with guests from the National Cancer Institute (NCI), to discuss the progress and future of the ASPREE trial and sub-studies.<\/p>\r\n\r\n\r\n\r\n

The\u00a0Berman Center for Outcomes and Clinical Research<\/a>\u00a0co-ordinates conduct of the ASPREE trial in more than\u00a030 sites across the USA.<\/p>\r\n\r\n\r\n\r\n

Approximately 80 national and international senior researchers are collaborating on the principal ASPREE trial and\/or an\u00a0ASPREE sub-study<\/a>.<\/p>\r\n\r\n\r\n\r\n

ASPREE sub-studies include: ACES (aspirin and cancer); ALSOP \u2013 questionnaires identifying medical and social factors that may affect the ability to age well; ASPREE-AMD (aspirin and age-related macular degeneration); ASPREE-ANTISEPSIS (aspirin and severe infection); ASPREE-D (aspirin and depression); ASPREE- FRACTURES (aspirin and falls and fractures); ASPREE-HEARING (aspirin and age-related hearing loss); ASPREE-Knee (aspirin and osteoarthritis); ASPREE-NEURO (aspirin and microvascular bleeds in the brain); ENVIS-ion \u2013 changes in retinal and brain vasculature and SNORE-ASA (aspirin and obstructive sleep apnoea).<\/p>\r\n\r\n\r\n\r\n

The ASPREE Healthy Ageing Biobank, which is collecting follow-up blood samples three years after the first collection, is a repository for biological indicators of health (or disease). Two genomic sub-studies are in collaboration with the Garvan Institute of Medical Research and the Mount Sinai School of Medicine in New York. Two new sub-studies are investigating the effect of androgens on cardiovascular health and mortality in ASPREE women (SHOW), and measuring levels of inflammatory biomarkers in plasma donated by ASPREE participants to the ASPREE Healthy Ageing Biobank.<\/p>\r\n\r\n\r\n\r\n

The NCI (National Cancer Institute<\/a>, a branch of the National Institutes of Health in the U.S.) awarded in 2012-2013 funding to collect cancer information and additional blood and urine samples and tumour samples from ASPREE participants for cancer research.<\/p>\r\n\r\n\r\n\r\n

Recently, the\u00a0NHMRC\u00a0<\/a>awarded to Monash University grants\u00a0for\u00a0completion of the ASPREE trial and to further investigate the effect of low-dose aspirin on colorectal cancer in older adults.<\/p>\r\n\r\n\r\n\r\n

\"The\r\n
Above: In January this year, the Australian ASPREE team welcomed to SPHPM, Monash University, U.S. collaborators from the Berman Center for Outcomes and Clinical Research and guests from the National Cancer Institute (NCI). Back row (from left) Prof Mark Nelson, A\/Prof Robyn Woods (ASPREE Exec Officer), Prof Danny Liew, Dr Jessica Lockery, Dr Suzanne Orchard, Dr Sharyn Fitzgerald, Dr Emily Parker, Dr Andrew Haydon. Front row (from left) Dr Paul Lacaze, Prof Chris Reid, Dr Leslie Ford (NCI), Prof Anne Murray (Berman), Prof John McNeil (ASPREE PI), Dr Asad Umar (NCI), A\/Prof Andrew Chan (Massachusettes General Hospital), Prof Colin Johnstone, Ms Brenda Kirpach (Berman), Dr Carlene Britt, Prof Rory Wolfe, Ms Megan Dumas. <\/em><\/figcaption>\r\n<\/figure>\r\n\r\n\r\n\r\n

Updated 27.02.2021<\/p>\r\n\r\n\r\n\r\n

 <\/p>\r\n","protected":false},"excerpt":{"rendered":"

ASPREE US and Australian collaborators from the Berman Center for Outcomes and Clinical Research met up to discuss the trial’s progress earlier this month.<\/p>\n","protected":false},"author":2,"featured_media":6519,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"1200","footnotes":""},"categories":[17,18,16],"tags":[47,46,48,49],"_links":{"self":[{"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/posts\/4695"}],"collection":[{"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/comments?post=4695"}],"version-history":[{"count":11,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/posts\/4695\/revisions"}],"predecessor-version":[{"id":8305,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/posts\/4695\/revisions\/8305"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/media\/6519"}],"wp:attachment":[{"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/media?parent=4695"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/categories?post=4695"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aspree.org\/aus\/wp-json\/wp\/v2\/tags?post=4695"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}